{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:13:59Z","timestamp":1771640039379,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4-6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s11864-008-0082-0","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T19:57:48Z","timestamp":1234987068000},"page":"251-258","source":"Crossref","is-referenced-by-count":7,"title":["Skin Cancer and the Solid Organ Transplant Recipient"],"prefix":"10.1007","volume":"9","author":[{"given":"M. J.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J.","family":"Li\u00e9geois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"82_CR1","first-page":"700","volume":"29","author":"TS Housman","year":"2003","unstructured":"Housman TS, Williford PM, Feldman SR, et al. Nonmelanoma skin cancer: an episode of care management approach. Dermatol Surg 2003;29:700\u2013711. doi: 10.1046\/j.1524-4725.2003.29185.x .","journal-title":"Dermatol Surg"},{"key":"82_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mjd.2003.186","volume":"48","author":"TS Housman","year":"2003","unstructured":"Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003;48:425\u2013429. doi: 10.1067\/mjd.2003.186 .","journal-title":"J Am Acad Dermatol"},{"key":"82_CR3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2008.05.015","volume":"59","author":"DC Dapprich","year":"2008","unstructured":"Dapprich DC, Weenig RH, Rohlinger AL, et al. Outcomes of melanoma in recipients of solid organ transplant. J Am Acad Dermatol 2008;59:405\u2013417. doi: 10.1016\/j.jaad.2008.05.015 .","journal-title":"J Am Acad Dermatol"},{"key":"82_CR4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/cncr.21698","volume":"106","author":"JL Andruchow","year":"2006","unstructured":"Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006;106:1078\u20131083. doi: 10.1002\/cncr.21698 .","journal-title":"Cancer"},{"key":"82_CR5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archotol.131.7.551","volume":"131","author":"CJ O\u2019Brien","year":"2005","unstructured":"O\u2019Brien CJ. The parotid gland as a metastatic basin for cutaneous cancer. Arch Otolaryngol Head Neck Surg 2005;131:551\u2013555. doi: 10.1001\/archotol.131.7.551 .","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"82_CR6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hed.10063","volume":"24","author":"CJ O\u2019Brien","year":"2002","unstructured":"O\u2019Brien CJ, McNeil EB, McMahon JD, et al. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002;24:417\u2013422. doi: 10.1002\/hed.10063 .","journal-title":"Head Neck"},{"key":"82_CR7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/hed.1106","volume":"23","author":"CJ O\u2019Brien","year":"2001","unstructured":"O\u2019Brien CJ, McNeil EB, McMahon JD, et al. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck 2001;23:744\u2013748. doi: 10.1002\/hed.1106 .","journal-title":"Head Neck"},{"key":"82_CR8","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00005537-200310000-00031","volume":"113","author":"MJ Veness","year":"2003","unstructured":"Veness MJ, Palme CE, Smith M, et al. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope 2003;113:1827\u20131833. doi: 10.1097\/00005537-200310000-00031 .","journal-title":"Laryngoscope"},{"key":"82_CR9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","volume":"9","author":"KD Brantsch","year":"2008","unstructured":"Brantsch KD, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008;9:713\u2013720. doi: 10.1016\/S1470-2045(08)70178-5 .","journal-title":"Lancet Oncol"},{"key":"82_CR10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","volume":"344","author":"M Alam","year":"2001","unstructured":"Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001;344:975\u2013983. doi: 10.1056\/NEJM200103293441306 .","journal-title":"N Engl J Med"},{"key":"82_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.TP.0000108491.62935.DF","volume":"77","author":"C Bordea","year":"2004","unstructured":"Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004;77:574\u2013579. doi: 10.1097\/01.TP.0000108491.62935.DF .","journal-title":"Transplantation"},{"key":"82_CR12","doi-asserted-by":"crossref","unstructured":"Hess SD, Schmults C: The clinical presentation and diagnosis of skin cancer in organ transplant recipients. In Skin Disease in Organ Transplantation. Edited by Otley C, Stasko T. Chapter 22, Cambridge; 2008","DOI":"10.1017\/CBO9780511547379.026"},{"key":"82_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.22765","volume":"110","author":"CK Bichakjian","year":"2007","unstructured":"Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007;110:1\u201312. doi: 10.1002\/cncr.22765 .","journal-title":"Cancer"},{"key":"82_CR14","doi-asserted-by":"crossref","unstructured":"Mullen JT, Feng L, Xing Y, et al.: Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006, 13:902\u2013909","DOI":"10.1245\/ASO.2006.07.022"},{"key":"82_CR15","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0041-1345(03)00669-9","volume":"35","author":"R Marcen","year":"2003","unstructured":"Marcen R, Pascual J, Tato AM, et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003;35:1714\u20131716. doi: 10.1016\/S0041-1345(03)00669-9 .","journal-title":"Transplant Proc"},{"key":"82_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0190-9622(99)70525-6","volume":"40","author":"CS Ong","year":"1999","unstructured":"Ong CS, Keogh AM, Kossard S, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999;40:27\u201334. doi: 10.1016\/S0190-9622(99)70525-6 .","journal-title":"J Am Acad Dermatol"},{"key":"82_CR17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ncponc0883","volume":"4","author":"JA Neville","year":"2007","unstructured":"Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 2007;4:462\u2013469. doi: 10.1038\/ncponc0883 .","journal-title":"Nat Clin Pract Oncol"},{"key":"82_CR18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1540-9740.2004.02458.x","volume":"3","author":"K Nouri","year":"2004","unstructured":"Nouri K, Rivas MP. A primer of Mohs micrographic surgery: common indications. Skinmed 2004;3:191\u2013196. doi: 10.1111\/j.1540-9740.2004.02458.x .","journal-title":"Skinmed"},{"key":"82_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/S0190-9622(03)01835-8","volume":"49","author":"AS Clayton","year":"2003","unstructured":"Clayton AS, Stasko T. Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey. J Am Acad Dermatol 2003;49:413\u20136. doi: 10.1067\/S0190-9622(03)01835-8 .","journal-title":"J Am Acad Dermatol"},{"key":"82_CR20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.6004\/jnccn.2007.0045","volume":"5","author":"SJ Miller","year":"2007","unstructured":"Miller SJ, Alam M, Andersen J, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2007;5:506\u2013529.","journal-title":"J Natl Compr Canc Netw"},{"key":"82_CR21","unstructured":"Li\u00e9geois NJ, et al.: Communication DLp. (in pre- paration)"},{"key":"82_CR22","unstructured":"http:\/\/www.nccn.org\/"},{"key":"82_CR23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hed.20048","volume":"26","author":"N Audet","year":"2004","unstructured":"Audet N, Palme CE, Gullane PJ, et al. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck 2004;26:727\u2013732. doi: 10.1002\/hed.20048 .","journal-title":"Head Neck"},{"key":"82_CR24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","volume":"27","author":"MA Stanley","year":"2002","unstructured":"Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 2002;27:571\u2013577. doi: 10.1046\/j.1365-2230.2002.01151.x .","journal-title":"Clin Exp Dermatol"},{"key":"82_CR25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2133.2004.06094.x","volume":"151","author":"D Vidal","year":"2004","unstructured":"Vidal D, Matias-Guiu X, Alomar A. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis. Br J Dermatol 2004;151:656\u2013662. doi: 10.1111\/j.1365-2133.2004.06094.x .","journal-title":"Br J Dermatol"},{"key":"82_CR26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.TP.0000113445.02908.06","volume":"77","author":"BM Prinz","year":"2004","unstructured":"Prinz BM, Hafner J, Dummer R, et al. Treatment of Bowen\u2019s disease with imiquimod 5% cream in transplant recipients. Transplantation 2004;77:790\u2013791. doi: 10.1097\/01.TP.0000113445.02908.06 .","journal-title":"Transplantation"},{"key":"82_CR27","first-page":"561","volume":"27","author":"KJ Smith","year":"2001","unstructured":"Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen\u2019s disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 2001;27:561\u2013564. doi: 10.1046\/j.1524-4725.2001.00149.x .","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"82_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","volume":"157","author":"C Ulrich","year":"2007","unstructured":"Ulrich C, Bichel J, Euvrard S, et al. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 2007;157 Suppl 2:25\u201331.","journal-title":"Br J Dermatol"},{"key":"82_CR29","first-page":"656","volume":"30","author":"YG Graaf De","year":"2004","unstructured":"De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004;30:656\u2013661. doi: 10.1111\/j.1524-4725.2004.30152.x .","journal-title":"Dermatol Surg"},{"key":"82_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archderm.1985.01660020065019","volume":"121","author":"E Epstein","year":"1985","unstructured":"Epstein E. Fluorouracil paste treatment of thin basal cell carcinomas. Arch Dermatol 1985;121:207\u2013213. doi: 10.1001\/archderm.121.2.207 .","journal-title":"Arch Dermatol"},{"issue":"Suppl 1","key":"82_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000252594","volume":"140","author":"GF Klostermann","year":"1970","unstructured":"Klostermann GF. Effects of 5-fluorouracil (5-FU) ointment on normal and diseased skin. Histological findings and deep action. Dermatologica 1970;140:Suppl 1:47\u201354.","journal-title":"Dermatologica"},{"key":"82_CR32","first-page":"433","volume":"33","author":"K Gross","year":"2007","unstructured":"Gross K, Kircik L, Kricorian G. 5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007;33:433\u2013439; discussion 440. doi: 10.1111\/j.1524-4725.2007.33090.x .","journal-title":"Dermatol Surg"},{"key":"82_CR33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2005.06347.x","volume":"152","author":"K Chen","year":"2005","unstructured":"Chen K, Craig JC, Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol 2005;152:518\u2013523. doi: 10.1111\/j.1365-2133.2005.06347.x .","journal-title":"Br J Dermatol"},{"key":"82_CR34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-0012.2005.00412.x","volume":"19","author":"BT Kovach","year":"2005","unstructured":"Kovach BT, Sams HH, Stasko T. Systemic strategies for chemoprevention of skin cancers in transplant recipients. Clin Transplant 2005;19:726\u2013734.","journal-title":"Clin Transplant"},{"key":"82_CR35","first-page":"562","volume":"32","author":"CC Otley","year":"2006","unstructured":"Otley CC, Stasko T, Tope WD, Lebwohl M. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 2006;32:562\u2013568. doi: 10.1111\/j.1524-4725.2006.32115.x .","journal-title":"Dermatol Surg"},{"key":"82_CR36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2007.08203.x","volume":"157","author":"CC Otley","year":"2007","unstructured":"Otley CC, Griffin MD, Charlton MR, Edwards BS, Neuburg M, Stasko T. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks. Br J Dermatol 2007;157:1183\u20131188. doi: 10.1111\/j.1365-2133.2007.08203.x .","journal-title":"Br J Dermatol"},{"key":"82_CR37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","volume":"154","author":"CC Otley","year":"2006","unstructured":"Otley CC, Berg D, Ulrich C, et al. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 2006;154:395\u2013400. doi: 10.1111\/j.1365-2133.2005.07087.x .","journal-title":"Br J Dermatol"},{"key":"82_CR38","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/sj.bjc.6602162","volume":"91","author":"S Chan","year":"2004","unstructured":"Chan S. Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer. Br J Cancer 2004;91:1420\u20131424. doi: 10.1038\/sj.bjc.6602162 .","journal-title":"Br J Cancer"},{"key":"82_CR39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","volume":"80","author":"HM Kauffman","year":"2005","unstructured":"Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005;80:883-889. doi: 10.1097\/01.TP.0000184006.43152.8D .","journal-title":"Transplantation"},{"key":"82_CR40","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/S0041-1345(03)00351-8","volume":"35","author":"BD Kahan","year":"2003","unstructured":"Kahan BD, Knight R, Schoenberg L, et al. Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience. Transplant Proc 2003;35:25S\u201334S. doi: 10.1016\/S0041-1345(03)00351-8 .","journal-title":"Transplant Proc"},{"key":"82_CR41","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0012.2004.00188.x","volume":"18","author":"T Mathew","year":"2004","unstructured":"Mathew T, Kreis H, Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004;18:446\u20139. doi: 10.1111\/j.1399-0012.2004.00188.x .","journal-title":"Clin Transplant"},{"key":"82_CR42","unstructured":"Sumaira A: Skin cancer prevention and photoprotection in organ transplant. In Skin Disease in Organ Transplantation. Edited by Otley C, Stasko T. Chapter 46, Cambridge; 2008"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-008-0082-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-008-0082-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-008-0082-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:34:19Z","timestamp":1559432059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-008-0082-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":42,"journal-issue":{"issue":"4-6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s11864-008-0082-0","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}